191 related articles for article (PubMed ID: 15102853)
1. Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design.
Saravanamuthu A; Vickers TJ; Bond CS; Peterson MR; Hunter WN; Fairlamb AH
J Biol Chem; 2004 Jul; 279(28):29493-500. PubMed ID: 15102853
[TBL] [Abstract][Full Text] [Related]
2. Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity.
Stoll VS; Simpson SJ; Krauth-Siegel RL; Walsh CT; Pai EF
Biochemistry; 1997 May; 36(21):6437-47. PubMed ID: 9174360
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the Trypanosoma cruzi trypanothione reductase.mepacrine complex.
Jacoby EM; Schlichting I; Lantwin CB; Kabsch W; Krauth-Siegel RL
Proteins; 1996 Jan; 24(1):73-80. PubMed ID: 8628734
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of trypanothione reductase and glutathione reductase by trivalent organic arsenicals.
Cunningham ML; Zvelebil MJ; Fairlamb AH
Eur J Biochem; 1994 Apr; 221(1):285-95. PubMed ID: 8168518
[TBL] [Abstract][Full Text] [Related]
5. Redox enzyme engineering: conversion of human glutathione reductase into a trypanothione reductase.
Bradley M; Bücheler US; Walsh CT
Biochemistry; 1991 Jun; 30(25):6124-7. PubMed ID: 2059620
[TBL] [Abstract][Full Text] [Related]
6. The structure of Trypanosoma cruzi trypanothione reductase in the oxidized and NADPH reduced state.
Lantwin CB; Schlichting I; Kabsch W; Pai EF; Krauth-Siegel RL
Proteins; 1994 Feb; 18(2):161-73. PubMed ID: 8159665
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
[TBL] [Abstract][Full Text] [Related]
8. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
9. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds.
Jockers-Scherübl MC; Schirmer RH; Krauth-Siegel RL
Eur J Biochem; 1989 Mar; 180(2):267-72. PubMed ID: 2647489
[TBL] [Abstract][Full Text] [Related]
10. Inhibiting effects of spermidine derivatives on Trypanosoma cruzi trypanothione reductase.
O'Sullivan MC; Dalrymple DM; Zhou Q
J Enzyme Inhib; 1996 Oct; 11(2):97-114. PubMed ID: 9204399
[TBL] [Abstract][Full Text] [Related]
11. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures.
Benson TJ; McKie JH; Garforth J; Borges A; Fairlamb AH; Douglas KT
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):9-11. PubMed ID: 1355650
[TBL] [Abstract][Full Text] [Related]
12. Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi.
Jones DC; Ariza A; Chow WH; Oza SL; Fairlamb AH
Mol Biochem Parasitol; 2010 Jan; 169(1):12-9. PubMed ID: 19747949
[TBL] [Abstract][Full Text] [Related]
13. Site-directed mutagenesis of the redox-active cysteines of Trypanosoma cruzi trypanothione reductase.
Borges A; Cunningham ML; Tovar J; Fairlamb AH
Eur J Biochem; 1995 Mar; 228(3):745-52. PubMed ID: 7737173
[TBL] [Abstract][Full Text] [Related]
14. Rational design of selective ligands for trypanothione reductase from Trypanosoma cruzi. Structural effects on the inhibition by dibenzazepines based on imipramine.
Garforth J; Yin H; McKie JH; Douglas KT; Fairlamb AH
J Enzyme Inhib; 1997 Aug; 12(3):161-73. PubMed ID: 9314113
[TBL] [Abstract][Full Text] [Related]
15. Structural analysis and molecular docking of trypanocidal aryloxy-quinones in trypanothione and glutathione reductases: a comparison with biochemical data.
Vera B; Vázquez K; Mascayano C; Tapia RA; Espinosa V; Soto-Delgado J; Salas CO; Paulino M
J Biomol Struct Dyn; 2017 Jun; 35(8):1785-1803. PubMed ID: 27232454
[TBL] [Abstract][Full Text] [Related]
16. (2,2':6',2"-Terpyridine)platinum(II) complexes are irreversible inhibitors of Trypanosoma cruzi trypanothione reductase but not of human glutathione reductase.
Bonse S; Richards JM; Ross SA; Lowe G; Krauth-Siegel RL
J Med Chem; 2000 Dec; 43(25):4812-21. PubMed ID: 11123991
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Trypanosoma cruzi trypanothione reductase by acridines: kinetic studies and structure-activity relationships.
Bonse S; Santelli-Rouvier C; Barbe J; Krauth-Siegel RL
J Med Chem; 1999 Dec; 42(26):5448-54. PubMed ID: 10639286
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of parasite trypanothione reductase: acquisition of glutathione reductase activity in a triple mutant.
Sullivan FX; Sobolov SB; Bradley M; Walsh CT
Biochemistry; 1991 Mar; 30(11):2761-7. PubMed ID: 2007114
[TBL] [Abstract][Full Text] [Related]
19. Trypanothione reductase from Trypanosoma cruzi. Purification and characterization of the crystalline enzyme.
Krauth-Siegel RL; Enders B; Henderson GB; Fairlamb AH; Schirmer RH
Eur J Biochem; 1987 Apr; 164(1):123-8. PubMed ID: 3549299
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of trypanothione reductase by substrate analogues.
Garrard EA; Borman EC; Cook BN; Pike EJ; Alberg DG
Org Lett; 2000 Nov; 2(23):3639-42. PubMed ID: 11073664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
